Exicure Inc
General ticker "XCUR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $40.0M
Exicure Inc follows the US Stock Market performance with the rate: 27.5%.
Estimated limits based on current volatility of 6.8%: low 18.04$, high 20.65$
Factors to consider:
- Current price 117.3% above estimated high
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [3.89$, 11.60$]
- 2023-12-31 to 2024-12-30 estimated range: [3.18$, 8.99$]
Financial Metrics affecting the XCUR estimates:
- Negative: Non-GAAP EPS, $ of -3.51 <= 0.10
- Negative: Operating profit margin, % of -5.97 <= 1.03
- Negative: Operating cash flow per share per price, % of -62.03 <= 2.35
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -21.66 <= 3.85
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0.13 <= 0.14
- Negative: Industry earnings per price (median), % of -24.66 <= 1.31
Short-term XCUR quotes
Long-term XCUR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $28.83MM | $0.00MM |
| Operating Expenses | $62.55MM | $30.66MM | $15.00MM |
| Operating Income | $-62.55MM | $-1.83MM | $-15.00MM |
| Non-Operating Income | $-1.55MM | $-0.54MM | $-1.92MM |
| Interest Expense | $1.69MM | $0.59MM | $0.00MM |
| R&D Expense | $48.98MM | $19.77MM | $1.42MM |
| Income(Loss) | $-64.10MM | $-2.37MM | $-16.91MM |
| Taxes | $0.00MM | $0.21MM | $0.00MM |
| Profit(Loss) | $-64.10MM | $-2.58MM | $-16.91MM |
| Stockholders Equity | $11.23MM | $14.92MM | $3.03MM |
| Inventory | $0.00MM | $0.51MM | $0.00MM |
| Assets | $64.87MM | $23.33MM | $11.58MM |
| Operating Cash Flow | $-34.82MM | $-35.66MM | $-10.36MM |
| Capital expenditure | $0.97MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $43.09MM | $4.70MM | $-1.08MM |
| Financing Cash Flow | $1.12MM | $-3.10MM | $3.67MM |
| Earnings Per Share* | $-21.70 | $-0.56 | $-2.11 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.